These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9017366)

  • 1. Evidence of a butterfly-like configuration of structurally diverse allosteric inhibitors of the HIV-1 reverse transcriptase.
    Mager PP
    Drug Des Discov; 1996 Dec; 14(3):241-57. PubMed ID: 9017366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase.
    Tachedjian G; Orlova M; Sarafianos SG; Arnold E; Goff SP
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7188-93. PubMed ID: 11416202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-reverse transcriptase inhibition: inclusion of ligand-induced fit by cross-docking studies.
    Ragno R; Frasca S; Manetti F; Brizzi A; Massa S
    J Med Chem; 2005 Jan; 48(1):200-12. PubMed ID: 15634014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
    Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of NNRTIs on HIV reverse transcriptase dimerization.
    Tachedjian G; Goff SP
    Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance analysis and molecular modeling of nonnucleoside reverse transcriptase inhibitors targeting drug-resistance mutations in the reverse transcriptase of human immunodeficiency virus.
    Yang SS; Pattabiraman N; Gussio R; Pallansch L; Buckheit RW; Bader JP
    Leukemia; 1997 Apr; 11 Suppl 3():89-92. PubMed ID: 9209308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A check on rational drug design: molecular simulation of the allosteric inhibition of HIV-1 reverse transcriptase.
    Mager PP
    Med Res Rev; 1997 May; 17(3):235-76. PubMed ID: 9127858
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes.
    Klunder JM; Hoermann M; Cywin CL; David E; Brickwood JR; Schwartz R; Barringer KJ; Pauletti D; Shih CK; Erickson DA; Sorge CL; Joseph DP; Hattox SE; Adams J; Grob PM
    J Med Chem; 1998 Jul; 41(16):2960-71. PubMed ID: 9685235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated reverse isoxazolidinyl nucleosides: a new class of allosteric HIV-1 reverse transcriptase inhibitors.
    Romeo R; Giofrè SV; Macchi B; Balestrieri E; Mastino A; Merino P; Carnovale C; Romeo G; Chiacchio U
    ChemMedChem; 2012 Apr; 7(4):565-9. PubMed ID: 22323191
    [No Abstract]   [Full Text] [Related]  

  • 10. Hybrid canonical-correlation neural-network approach applied to nonnucleoside HIV-1 reverse transcriptase inhibitors (HEPT derivatives).
    Mager PP
    Curr Med Chem; 2003 Sep; 10(17):1643-59. PubMed ID: 12871114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
    Zhou T; Xie L
    Yao Xue Xue Bao; 2004 Aug; 39(8):666-72. PubMed ID: 15563074
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010).
    Zhan P; Liu X
    Expert Opin Ther Pat; 2011 May; 21(5):717-96. PubMed ID: 21457080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design.
    Zhan P; Chen X; Li D; Fang Z; De Clercq E; Liu X
    Med Res Rev; 2013 Jun; 33 Suppl 1():E1-72. PubMed ID: 21523792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses.
    Tucker TJ; Sisko JT; Tynebor RM; Williams TM; Felock PJ; Flynn JA; Lai MT; Liang Y; McGaughey G; Liu M; Miller M; Moyer G; Munshi V; Perlow-Poehnelt R; Prasad S; Reid JC; Sanchez R; Torrent M; Vacca JP; Wan BL; Yan Y
    J Med Chem; 2008 Oct; 51(20):6503-11. PubMed ID: 18826204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future.
    De Clercq E
    Chem Biodivers; 2004 Jan; 1(1):44-64. PubMed ID: 17191775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling approach to understanding the mode of action of L-nucleosides as antiviral agents.
    Lee K; Chu CK
    Antimicrob Agents Chemother; 2001 Jan; 45(1):138-44. PubMed ID: 11120956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification and regression trees--studies of HIV reverse transcriptase inhibitors.
    Daszykowski M; Walczak B; Xu QS; Daeyaert F; de Jonge MR; Heeres J; Koymans LM; Lewi PJ; Vinkers HM; Janssen PA; Massart DL
    J Chem Inf Comput Sci; 2004; 44(2):716-26. PubMed ID: 15032554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design, synthesis, and in vitro assay of novel nucleoside analog inhibitors against HIV-1 reverse transcriptase.
    Liu X; Xie W; Huang RH
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3775-7. PubMed ID: 15993595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance.
    Geitmann M; Unge T; Danielson UH
    J Med Chem; 2006 Apr; 49(8):2375-87. PubMed ID: 16610781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
    Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Jiménez-Barbero J; Castillo R
    Bioorg Med Chem; 2004 Dec; 12(23):6085-95. PubMed ID: 15519154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.